O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings ...

C4 Therapeutics Inc. (NASDAQ:CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, ...

Beaten-down biotech stocks like ALT, IBRX and MCRB are eyeing a 2026 rebound as FDA alignment, pipeline progress and approvals fuel optimism.

Solid Biosciences, valued at $463 million, will have updated Phase I/II Duchenne muscular dystrophy data in 2026, along with three FDA meetings in the first half of the year to finalize Phase III ...

This stock is a great choice for cautious and aggressive investors.

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

Analysts might anticipate a good upside ahead for CSL shares, but I think this ASX biotech stock is a much better buy.